|
| [10] | J. Bangen, L. Hammerich, R. Sonntag, M. Baues, U. Haas, D. Lambertz, T. Longerich, T. Lammers, F. Tacke, C. Trautwein, C. Liedtke,
"Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice", Hepatology, vol. 66, no. 4, pp. 1242–1257.
|
| [9] | N. Beraza, Y. Malato, L. E. Sander, M. Al-Masaoudi, J. Freimuth, D. Riethmacher, G. J. Gores, T. Roskams, C. Liedtke, C. Trautwein,
"Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage", J. Exp. Med., vol. 206, no. 8, pp. 1727–1737.
|
| [8] | K. Bettermann, M. Vucur, J. Haybaeck, C. Koppe, J. Janssen, F. Heymann, A. Weber, R. Weiskirchen, C. Liedtke, N. Gassler, M. Müller, R. de Vos, M. J. Wolf, Y. Boege, G. M. Seleznik, N. Zeller, D. Erny, T. Fuchs, S. Zoller, S. Cairo, M. Buendia, M. Prinz, S. Akira, F. Tacke, M. Heikenwalder, C. Trautwein, T. Luedde,
"TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer", Cancer Cell, vol. 17, no. 5, pp. 481–496.
|
| [7] | J. Freimuth, J. Bangen, D. Lambertz, W. Hu, Y. A. Nevzorova, R. Sonntag, N. Gassler, D. Riethmacher, C. Trautwein, C. Liedtke,
"Loss of caspase-8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation", Hepatology, vol. 58, no. 5, pp. 1779–1789.
|
| [6] | W. Hu, Y. A. Nevzorova, U. Haas, N. Moro, P. Sicinski, Y. Geng, M. Barbacid, C. Trautwein, C. Liedtke,
"Concurrent deletion of cyclin E1 and cyclin-dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice", Hepatology, vol. 59, no. 2, pp. 651–660.
|
| [5] | C. Liedtke, J. Bangen, J. Freimuth, N. Beraza, D. Lambertz, F. J. Cubero, M. Hatting, K. R. Karlmark, K. L. Streetz, G. A. Krombach, F. Tacke, N. Gassler, D. Riethmacher, C. Trautwein,
"Loss of Caspase-8 Protects Mice Against Inflammation-Related Hepatocarcinogenesis but Induces Non-Apoptotic Liver Injury", Gastroenterology, vol. 141, no. 6, pp. 2176–2187.
|
| [4] | Y. A. Nevzorova, W. Hu, F. J. Cubero, U. Haas, J. Freimuth, F. Tacke, C. Trautwein, C. Liedtke,
"Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1832, no. 10, pp. 1765–1775.
|
| [3] | Y. A. Nevzorova, D. Tschaharganeh, N. Gassler, Y. Geng, R. Weiskirchen, P. Sicinski, C. Trautwein, C. Liedtke,
"Aberrant Cell Cycle Progression and Endoreplication in Regenerating Livers of Mice That Lack a Single E-Type Cyclin", Gastroenterology, vol. 137, no. 2, pp. 691–703.e6.
|
| [2] | Y. A. Nevzorova, J. Bangen, W. Hu, U. Haas, R. Weiskirchen, N. Gassler, S. Huss, F. Tacke, P. Sicinski, C. Trautwein, C. Liedtke,
"Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice", Hepatology, vol. 56, no. 3, pp. 1140–1149.
|
| [1] | R. Sonntag, N. Giebeler, Y. A. Nevzorova, J. Bangen, D. Fahrenkamp, D. Lambertz, U. Haas, W. Hu, N. Gassler, F. J. Cubero, G. Müller-Newen, A. T. Abdallah, R. Weiskirchen, F. Ticconi, I. G. Costa, M. Barbacid, C. Trautwein, C. Liedtke,
"Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma", Proc. Natl. Acad. Sci., vol. 115, no. 37, pp. 9282–9287.
|